Biology Services
Navigating the Future of Medicine: Transforming Health Outcomes with Cutting-Edge Biologics Expertise.
We accelerate your biologic innovation with our panoramic Biology Services
We are dedicated to advancing biologics through innovative solutions and expertise, guiding drug development from research to market launch, ensuring confidence in achieving therapeutic goals and navigating complexities.
- Overview
We cater comprehensive services for biologic drug development, covering early-stage research to post-market surveillance, ensuring the success of biologic therapies through end-to-end solutions.
Biologic medications, derived from living creatures, offer innovative therapies for various diseases. Zenovel’s Biologic Services assists in developing and launching complex biologics, providing comprehensive support that meets regulatory requirements, marking a new frontier in medicine.
- Our Services
- Why Choose Zenovel ?
- Modernized Facilities
Our state-of-the-art laboratories and production facilities utilize the latest technology to deliver reliable and high- quality outcomes.
- Articulate Solutions
Provides a comprehensive and efficient biologic development pathway by seamlessly integrating services throughout the entire lifecycle.
- Biologics Expert Professionals
Our team of scientists and regulatory experts is well-versed in biologic drug development, ensuring your projects benefit from the latest advancements and best practices.
- Quality Commitment
Ensures the quality and regulatory compliance of its biologic products, ensuring they meet all necessary requirements and are safe for patient use.
People Also Ask (FAQs)
Biology services in drug discovery involve biological testing and research used to evaluate potential drug candidates. These services often include cell-based assays, molecular biology studies, and in vitro testing to understand how compounds interact with biological systems.
Biology services help evaluate the activity, safety, and effectiveness of drug candidates by studying interactions with cells and biological pathways. These insights are critical for drug discovery. Zenovel supports this by ensuring structured evaluation, reliable data generation, and alignment with regulatory expectations for successful development.
Common biology services include cell-based assays, molecular biology studies, protein expression analysis, and biological screening tests to identify promising drug candidates. Zenovel supports these services by ensuring structured study design, reliable data generation, and alignment with regulatory expectations for effective preclinical development.
Biological research services help pharmaceutical companies evaluate drug targets, validate biological pathways, and assess the effectiveness of potential therapies. These services provide essential data needed to advance compounds into further stages of drug development.
Zenovel provides specialized biology services for drug discovery, including molecular biology research, biological assays, and in vitro testing support. Their expertise helps pharmaceutical companies accelerate drug discovery and generate high-quality biological data for development programs.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
